302: Vertex's big deal, biotech's red numbers, & an industry history lesson
Manage episode 411992359 series 2986293
How would you spend $13 billion in cash? Is biotech stale? And remember Dendreon?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss a multibillion-dollar deal from Vertex Pharmaceuticals with sweeping implications and a lengthy backstory. We also explain why gas prices are weighing on biotech, and make a surprise announcement.
325 つのエピソード